期刊文献+

羧基水溶性量子点在鼻咽癌标志物EBNA1标记中的应用 被引量:1

Application of carboxyl water-soluble quantum dots in nasopharyngeal carcinoma marker EBNA1 labeling
下载PDF
导出
摘要 目的探讨605nm羧基水溶性量子点在鼻咽癌标志物EB病毒核抗原1(EBNA1)中的标记方法。方法将605nm羧基水溶性量子点和鼻咽癌EBNA1在1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐的作用下共价交联,生成量子点标记的抗原,对标记后的抗原采用紫外可见吸收谱、荧光光谱测定,琼脂糖凝胶电泳分析。结果羧基水溶性量子点与鼻咽癌EBNA1抗原通过表面氨基与羧基缩合形成的稳定共价键,羧基水溶性量子点与鼻咽癌EBNA1抗原之间实现了成功连接,标记后荧光发射光谱检测结果表明,标记后的量子点EBNA1溶液的发射峰位置在380nm附近,保持良好的荧光特性。结论 605nm羧基水溶性量子点采用共价交联法可稳定标记鼻咽癌标志物EBNA1,为后续研究提供可靠依据。 Objective To explore the marking method of 605 nm carboxyl water-soluble quantum dots in nasopharyngeal carcinoma marker EBNA1.Methods The 605 nm carboxyl water-soluble quantum dots and nasopharyngeal carcinoma EBNA1 antigen were performed the covalent cross-linking under the action of 1-(3-dimethyl amino propyl)-3-2ethyl carbon imine hydrochloride,the quantum dots labeled antigen was generated,then the labeled antigen was detected by UV-Vis absorption spectroscopy,fluorescence spectrometry and agarose gel electrophoresis analysis.Results The stable covalent bond formation of carboxyl water-soluble quantum dots with nasopharyngeal carcinoma EBNA1 antigen by the surface amino and carboxyl condensation on was found,the carboxyl water-soluble quantum dots achieved the successful connection with EBNA1 nasopharyngeal carcinoma antigen,the labeled fluorescence emission spectrum detection results showed that the emission peak position of the labeled quantum dots EBNA1 solution was near 380 nm,keeping good fluorescence properties.Conclusion The 605 nm carboxyl water-soluble quantum dots can stably label nasopharyngeal carcinoma marker EBNA1 by adopting the covalent cross-linking method to provide reliable basis for subsequent research.
出处 《检验医学与临床》 CAS 2016年第6期721-723,共3页 Laboratory Medicine and Clinic
基金 国家自然科学基金资助项目(81170923)
关键词 羧基水溶性量子点 鼻咽癌 EBNA1 共价交联法 carboxyl water-soluble quantum dots nasopharyngeal carcinoma EBNA1 covalent cross linking method
  • 相关文献

参考文献18

  • 1Gwangsu Y,Jinhong P, Lee SSB, et al. Anisotropic charge Kondo effect in a triple quantum dot[J]. Phys Rev Lett, 2014,113 (23) : 236601.
  • 2Karki KJ,Widom JR, Seibt J, et al. Coherent two-dimen- sional photocurrent spectroscopy in a PbS quantum dot photocell[J]. Nat Commun, 2014,5 : 5869.
  • 3Blum AS, Moore MH, Ratna BR. Quantum dot fluores- cence as a function of alkyl chain length in aqueous envi- ronments[J]~. Langmuir, 2008,24(17) : 9194-9197.
  • 4Yum K, Wang N, Yu MF; Electrochemically controlled deconjugation and delivery of single quantum dots into the nucleus of living cells[J]. Small, 2010,6 (19): 2109- 2113.
  • 5Ebenstein Y,Gassman N, Kim S, et al. Combining atomic force and fluorescence microscopy for analysis of quan- tum-dot labeled protein-DNA complexes[J]. J Mol Recog- nit,2009,22(5) : 397-402.
  • 6Yong KT, Law WC, Hu R, et al. Nanotoxicity assessment of quantum dots: from cellular to primate studies[J]. Chem S0c Rev, 2013,42 (3) : 1236-1250.
  • 7Liu L, Yong KT, Roy I, et al. Bioconjugated pluronic triblock-copolymer micelle-encapsulated quantum dots for targeted imaging of cancer:in vitro and in vivo studies [J]. Theranostics,2012,2(7) : 705-713.
  • 8Folarin E,Ching-Wen C, May JL, et al. Bioconjugation of luminescent silicon quantum dots to gadolinium ions for bioimaging applications[J]. Nanoscale, 2012,4 ( 17 ): 5483- 5489.
  • 9Rui H, Wing-Cheung L, Guimiao L, et al. Pegylated phospho- lipid micelle-encapsulated near-infrared PbS quantum dots for in vitro and in vivo bioimaging[J]. Theranostics, 2012,2 ( 7 ) : 723-733.
  • 10Corey S,Janice T, Leone B, et al. Effective treatment of metastatic forms of Epstein-Barr virus-associated naso- pharyngeal carcinoma with a novel adenovirus-based a- doptive immunotherapy [ J ]. Cancer Res, 2012, 72 ( 5 ) : 1116-1125.

二级参考文献55

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量:132
  • 2张晓梅,钟建明,汤敏中,张晓光,廖建,郑裕明,邓洪,曾毅.EBV 4型IgA/VCA IgA/EA IgG/EA IgG/ZEBRA抗体在鼻咽癌普查和早期诊断中的应用[J].中华实验和临床病毒学杂志,2006,20(3):263-265. 被引量:15
  • 3任军,张晓梅,张晓光,李红霞,周玲,曾毅.以Rtac2/3为抗原用于鼻咽癌病人检测的初步研究[J].中华微生物学和免疫学杂志,2006,26(11):1057-1059. 被引量:31
  • 4Feng P, Ren EC, Liu D, et al. Expression of Epstein-Barr virus lyric gene BRLF 1 in nasopharyngeal carcinoma: potential use in diagnosis [J]. J Gen Virol, 2000, 81(10): 2417-23.
  • 5Feng P, Chan SH, Rachel Soo MY, et al. Antibody response to Epstein-Barr virus Rta protein in patients with nasopharngeal carcinoma[J]. Cancer, 2001, 92(7): 1872-80.
  • 6Cheng WM, Chan KH, Chen HL, et al. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum[J]. Int J Cancer, 2002, 97(4): 489-92.
  • 7Hitt MM, Allday M J, Hara T, et al. Epstein-Barr virus gene expression in a nasopharyngeal carcinoma-related tumour [J]. EMBO J, 1989, 8(9): 2639-51.
  • 8Tselis A, Jenson HB. Epstein-Barr Virus [M]. New York: Taylor & Francis Group, 2006: 276.
  • 9Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res, 2004, 10:803-821.
  • 10Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer, 2004, 4:757-768.

共引文献76

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部